This website is intended for use by individuals in the United States.

Can I participate?

Health Insurance is NOT required to participate.

Check if you may be able to participate in the NATiV3 trial

All patients, including the patients who where assigned to the placebo group during the first part of the study, will receive lanifibranor.

We recommend that you speak with your healthcare professional/physician about your interest in the NATiV3 trial. Together you can discuss other inclusion criteria that will need to be reviewed.

Locate a clinical trial site

Please look at the interactive map to locate your nearest study site or ask your healthcare professional for assistance.

Learn more

The links below provide additional information about liver function, NASH, clinical trials, and other organizations that work to promote education, treatment, and research options for liver disease.

Patient Advocacy Groups

Medical Information on NASH
Information about the Trial Sponsor